Periodontal Infection May Determine Best Treatment for Patients with RA

Thus, patients with RA who have a higher level of serum IgG to PPAD had less of a clinical response to bDMARDs. The investigators concluded their paper by suggesting that serum anti-PPAD IgG titers might be a useful biomarker for designing a personalized treatment strategy for RA.

Lara C. Pullen, PhD, is a medical writer based in the Chicago area.

Reference

Kobayashi T, Ito S, Kobayashi D, et al. Serum immunoglobulin G levels to porphyromonas gingivalis peptidylarginine deiminase affect clinical response to biological disease-modifying anti-rheumatic drug in rheumatoid arthritis. PLoS One. 2016 Apr 25;11(4):e0154182. doi: 10.1371/journal.pone.0154182. eCollection 2016.

The connection between periodontal disease and RA.

Evidence that suggests rheumatoid arthritis (RA) starts in mucosal sites such as the oral cavity and lung may lead to improved treatment and prevention of the disease

Established wisdom holds that patients with rheumatoid arthritis (RA) will fare better if their disease is diagnosed as early as possible, and treatments with disease-modifying drugs are started before inflammation can do more damage to joints and tissue. Usually, early diagnosis means spotting the clinical signs of disease, but new research tells us more about…

A review of data on antinuclear antibodies and tests for rheumatoid arthritis

Why Did Rheumatoid Arthritis Begin in 1800?

ACR/ARHP Annual Meeting 2012: Early Signs of Rheumatoid Arthritis May Appear Outside the Joints

Rheumatoid Arthritis Research Provides New Insights on Risk Factors, Identification Tools, Intervention

Laboratory Testing for Diagnosis, Management of Patients with Rheumatic Disease

Related Articles